Invivyd (IVVD) Other Working Capital Changes (2021 - 2025)
Invivyd (IVVD) reported Other Working Capital Changes of -$11.9 million for Q4 2025, down 187.1% on a YoY basis from $13.6 million in Q4 2024, and down 416.09% quarter-over-quarter from $3.8 million in Q3 2025.
Invivyd (IVVD) Other Working Capital Changes (2021 - 2025) Analysis & Trends
Invivyd has reported Other Working Capital Changes for 5 years, with the latest figure at -$11.9 million in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes fell 187.1% year-over-year to -$11.9 million; the trailing twelve-month figure through Dec 2025 stood at -$12.9 million (down 677.15% YoY), and the FY2025 full-year result was -$12.9 million, down 677.15% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$11.9 million, down from $3.8 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $22.9 million in Q4 2021, with the low at -$20.4 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged -$907600.0 across 5 years, with a median of -$406000.0 in 2024.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes slumped 657.21% — and 2024, when it surged 3512.0%.
- Invivyd's Other Working Capital Changes stood at $22.9 million in 2021, then slumped by 188.92% to -$20.4 million in 2022, then jumped by 98.04% to -$400000.0 in 2023, then surged by 3512.0% to $13.6 million in 2024, then slumped by 187.1% to -$11.9 million in 2025.
- The last three Other Working Capital Changes figures came in at -$11.9 million (Q4 2025), $3.8 million (Q3 2025), and -$4.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Invivyd | 168.41 Mn | -58.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.89 Mn |
| Dec 31, 2025 | -11.89 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Sep 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | -4.39 Mn |
| Jun 30, 2025 | -4.39 Mn |
| Mar 31, 2025 | -410,000.00 |
| Mar 31, 2025 | -410,000.00 |
| Dec 31, 2024 | 13.65 Mn |
| Dec 31, 2024 | 13.65 Mn |
| Sep 30, 2024 | -7.88 Mn |
| Sep 30, 2024 | -7.88 Mn |
| Jun 30, 2024 | -7.02 Mn |
| Jun 30, 2024 | -7.02 Mn |
| Mar 31, 2024 | -406,000.00 |
| Mar 31, 2024 | -406,000.00 |
| Dec 31, 2023 | -400,000.00 |
| Dec 31, 2023 | -400,000.00 |
| Sep 30, 2023 | -1.16 Mn |
| Sep 30, 2023 | -1.16 Mn |